Dialogue and collaboration
Over the years, as we have learnt from engagements with stakeholders, we have moved from stakeholder dialogue to building partnerships. We participate in and form interest groups with the goal of sharing best practise. Some examples illustrating the types of partnership we are engaged in:
- EPAA - The European Partnership for Alternative Approaches to Animal Testing
- CALAR - Centre for Applied Laboratory Animal Research
- DACOPA - Danish Consensus Platform for 3R Alternatives to Animal Experimentation. Member of ECOPA - the European platform
- BioSim - an EU sponsored Network of Excellence on Biosimulation
- BioLogue - Public-Private collaboration within biomedical sciences, research and education
- PSBR - The Pennsylvania Society for Biomedical Research
Awareness of stakeholders concerns
Novo Nordisk frequently meets with various stakeholders such as non-governmental organisations (NGOs), inter-governmental organisations (IGOs), governments and regulators, researchers, students and the press to discuss bioethical dilemmas. We participate in seminars, symposiums and conferences to share knowledge and views.
Novo Nordisk collaborates with institutions and authorities on guidelines for research, animal experimentation and environmental issues. Furthermore, we contribute to the scientific community by publishing research results and other types of data. A few examples are Novo Nordisk's state-of-the-art housing conditions for laboratory animals used in the textbook Comfortable Quarters for Laboratory Animals and on the webpages of The National Centre for the Replacement, Refinement and Reduction of Animals in Research.
